Showing results (1-10 of 183) with videos related to
Sort By:
Pageof 19
Cancers|March 29, 2023
Post-CDK 4/6 Inhibitor Therapy: Current Agents and Novel TargetsNadia Ashai, Sandra M SwainPharmacogenomics|November 9, 2023
Pharmacogenomic testing in oncology: a health system's approach to identify oncology provider perspectivesMeghna Bhatt, Beth N Peshkin, Sadaf Kazi, et al.Current Treatment Options in Oncology|May 31, 2019
Multimodality Management of Localized Biliary CancerNadia Ashai, Preethi Prasad, Lakshmi RajdevExpert Opinion on Pharmacotherapy|November 16, 2018
Nanoparticle albumin bound-paclitaxel for treatment of advanced non-small cell lung cancer: an evaluation of the clinical evidenceDiego Adrianzen Herrera, Nadia Ashai, Roman Perez-Soler, et al.NPJ Breast Cancer|May 21, 2021
HER2-positive breast cancer and tyrosine kinase inhibitors: the time is nowIlana Schlam, Sandra M SwainExpert Opinion on Drug Safety|March 17, 2016
Pertuzumab for the treatment of breast cancer: a safety reviewJennifer Gao, Sandra M SwainClinical Breast Cancer|December 15, 2010
CLEOPATRA: a phase III evaluation of pertuzumab and trastuzumab for HER2-positive metastatic breast cancerJosé Baselga, Sandra M SwainCancer|May 27, 2010
Primary systemic chemotherapy for inflammatory breast cancerSarah Sinclair, Sandra M SwainPageof 19